beta
TSRO
TESARO Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Tesaro Inc is an oncology-focused biopharmaceutical company. It focuses on developing treatments for cancer.
Market Cap: 3.86 Billion
Primary Exchange: Nasdaq Global Select
Website: http://www.tesarobio.com
Shares Outstanding: 54.4 Million
Float: 52.5 Million
Dividend: 0.0 (0.0%)
Beta: 1.23465
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 513 trading days
From: 2017-02-17 To: 2019-01-18
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|